Back
Zillow Group Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
35
ZG
Zillow Group
Last Price:
$77.35
Seasonality Move:
6.75%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$105.31
Seasonality Move:
1.75%
Sell
35
Zillow Group (ZG)
is a Sell
Is Zillow Group a Buy, Sell or Hold?
-
The current Zillow Group [ZG] share price is $76.89. The Score for ZG is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
ZG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZG Stock Price Chart
What is Zillow Group's stock price today?
-
The Zillow Group share price today is $76.89The current trend is moderately bearish and ZG is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $107.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
ZG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.22 | Buy |
Relative Strength Index (14 RSI): | 47.32 | Sell |
Chaikin Money Flow: | 664372 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.69 - 82.45) | Sell |
Bollinger Bands (100): | (62.5 - 79.28) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 33.84 | Sell |
Chaikin Money Flow: | -502758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.52 - 119.16) | Sell |
Bollinger Bands (100): | (114.38 - 127.78) | Sell |
ZG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.99 | Sell |
20-day SMA: | 79.4 | Sell |
50-day SMA: | 76.18 | Buy |
200-day SMA: | 59.06 | Buy |
8-day EMA: | 79.17 | Sell |
20-day EMA: | 78.72 | Sell |
50-day EMA: | 75.83 | Buy |
200-day EMA: | 63.68 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.57 | Sell |
20-day SMA: | 114.25 | Sell |
50-day SMA: | 119.8 | Sell |
200-day SMA: | 128.55 | Sell |
8-day EMA: | 110.88 | Sell |
20-day EMA: | 113.91 | Sell |
50-day EMA: | 117.81 | Sell |
200-day EMA: | 123.39 | Sell |
Zillow Group Earnings Growth & ZG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.04 per share, an increase this year of $0.35 per share, and an increase next year of $0.61 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Zillow Group Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |